McKinnon EJ - Search Results

1

Viral load detectability profiles for HIV infection.

McKinnon EJ, James IR, John M, Mallal SA. McKinnon EJ, et al. Stat Med. 2003 Feb 15;22(3):385-96. doi: 10.1002/sim.1325. Stat Med. 2003. PMID: 12529870

2

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.

Mallal SA, John M, Moore CB, James IR, McKinnon EJ. Mallal SA, et al. Among authors: mckinnon ej. AIDS. 2000 Jul 7;14(10):1309-16. doi: 10.1097/00002030-200007070-00002. AIDS. 2000. PMID: 10930144

3

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. John M, et al. Among authors: mckinnon ej. AIDS. 2001 Apr 13;15(6):717-23. doi: 10.1097/00002030-200104130-00007. AIDS. 2001. PMID: 11371686

4

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.

Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S. Nolan D, et al. AIDS. 2001 Jul 6;15(10):1275-80. doi: 10.1097/00002030-200107060-00009. AIDS. 2001. PMID: 11426072

5

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, Price P, Flexman JP, Tay-Kearney ML. French MA, et al. Among authors: mckinnon ej. HIV Med. 2000 Mar;1(2):107-15. doi: 10.1046/j.1468-1293.2000.00012.x. HIV Med. 2000. PMID: 11737333 Free article.

6

Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.

John M, McKinnon EJ, James IR, Nolan DA, Herrmann SE, Moore CB, White AJ, Mallal SA. John M, et al. Among authors: mckinnon ej. J Acquir Immune Defic Syndr. 2003 May 1;33(1):29-33. doi: 10.1097/00126334-200305010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12792352 Clinical Trial.

7

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S. Nolan D, et al. AIDS. 2003 Jun 13;17(9):1329-38. doi: 10.1097/00002030-200306130-00007. AIDS. 2003. PMID: 12799554

8

Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

Nolan D, Hammond E, James I, McKinnon E, Mallal S. Nolan D, et al. Antivir Ther. 2003 Dec;8(6):617-26. Antivir Ther. 2003. PMID: 14760896

9

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.

Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT. Gaudieri S, et al. Mol Immunol. 2005 Feb;42(4):557-60. doi: 10.1016/j.molimm.2004.07.041. Mol Immunol. 2005. PMID: 15607813 Review.

10

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.

Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT. Gaudieri S, et al. Genes Immun. 2005 Dec;6(8):683-90. doi: 10.1038/sj.gene.6364256. Genes Immun. 2005. PMID: 16121209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters